Comvita share buy back programme

16 December 2019

Comvita share buy back programme

Global natural health products company, Comvita Limited (“CVT”), plans to stand in market to
acquire up to 250,000 of its ordinary shares.

As a demonstration of commitment to his new role as CEO at Comvita, David Banfield has
committed to acquire $650,000 of shares in the company from Treasury Stock at market value,
such acquisition likely to occur in February during an open trading window.

To fund the purchase of Comvita shares, David will pay $200,000 and the balance will be funded
via an interest free loan from the company to David.*

Comvita therefore proposes to acquire its own equity securities by offers made through NZX’s
order matching market as follows:

Offer date: The maximum period during which offers will be made is from and including
20 December 2019 (being three clear business days after the date of this Notice) to
31 March 2020.

Equity securities to be acquired: The equity securities to be acquired are up to a total of 250,000
ordinary shares, being approximately 0.5% of CVT’s total ordinary shares.

*The transfer of shares from Treasury Stock and the provision of an interest free loan to David is
subject to the Company complying with all relevant requirements contained in the Companies Act
1993 and the NZX Listing Rules.

Ends.

For further information:
Brett Hewlett, Comvita Executive Director, 021 740 160
Neil Craig, Comvita Chairman, 021 731 509

Background information
About Comvita (www.comvita.co.nz)
Comvita (NZX:CVT) is a global natural health company committed to the development of innovative
products, backed by ongoing investment in scientific research.